LON:IXI Ixico Share Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Ixico Plc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 83 0.00 (0.00 %) (As of 09/25/2020 12:00 AM ET) Add Compare Share Today's Range 81.84Now: GBX 83▼ 83.3550-Day Range 63MA: GBX 77.40▼ 9152-Week Range 41.50Now: GBX 83▼ 98Volume27,900 shsAverage Volume98,388 shsMarket Capitalization£39.09 millionP/E Ratio55.33Dividend YieldN/ABetaN/A ProfileAnalyst RatingsChartCompetitorsEarningsInsider TradesHeadlines IXICO plc provides technology enabled services to the biopharmaceutical industry worldwide. The company's technologies include Assessa, a secure online digital platform that provides clinical decision support for patient selection and post-marketing surveillance; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, QC, and reading/analysis to reporting and data transfer. The company offers end-to-end imaging services, primarily in the fields of Alzheimer's, Parkinson's, Huntington's, multiple sclerosis, cerebrovascular, and progressive supranuclear palsy diseases; and engages in the data collection and analysis of neurological diseases. Its services are used to select patients for clinical trials, assess the safety and efficacy of new drugs in development, and in post marketing surveillance. The company was incorporated in 1995 and is based in London, the United Kingdom.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Ixico. Previous Next 2.7 Community Rank Outperform VotesIxico has received 139 “outperform” votes. (Add your “outperform” vote.)Underperform VotesIxico has received 114 “underperform” votes. (Add your “underperform” vote.)Community SentimentIxico has received 54.94% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Ixico and other stocks. Vote “Outperform” if you believe IXI will outperform the S&P 500 over the long term. Vote “Underperform” if you believe IXI will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldIxico does not currently pay a dividend.Dividend GrowthIxico does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Ixico insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Ixico is 55.33, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 18.39.Price to Earnings Ratio vs. SectorThe P/E ratio of Ixico is 55.33, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.62.Price to Book Value per Share RatioIxico has a P/B Ratio of 4.59. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.54 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:IXI Previous Symbol CUSIPN/A CIKN/A Webixico.com Phone+44-20-37637499Debt Debt-to-Equity RatioN/A Current Ratio5.01 Quick Ratio5.01Price-To-Earnings Trailing P/E Ratio55.33 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£8.69 million Price / Sales4.50 Cash FlowGBX 14.55 per share Price / Cash Flow5.70 Book ValueGBX 18.10 per share Price / Book4.59Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees67 Outstanding Shares47,091,300Market Cap£39.09 million Next Earnings Date12/7/2020 (Estimated) OptionableNot Optionable GBX 83 0.00 (0.00 %) (As of 09/25/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive IXI News and Ratings via Email Sign-up to receive the latest news and ratings for IXI and its competitors with MarketBeat's FREE daily newsletter. Ixico (LON:IXI) Frequently Asked Questions How has Ixico's stock been impacted by Coronavirus? Ixico's stock was trading at GBX 57 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, IXI shares have increased by 45.6% and is now trading at GBX 83. View which stocks have been most impacted by COVID-19. When is Ixico's next earnings date? Ixico is scheduled to release its next quarterly earnings announcement on Monday, December 7th 2020. View our earnings forecast for Ixico. How were Ixico's earnings last quarter? Ixico Plc (LON:IXI) announced its quarterly earnings data on Wednesday, May, 20th. The company reported $1.01 earnings per share (EPS) for the quarter. View Ixico's earnings history. Who are some of Ixico's key competitors? Some companies that are related to Ixico include Horizon Discovery Group (HZD), Exicure (XCUR), Exicure (XCUR), AquaBounty Technologies (AQB), Lineage Cell Therapeutics (LCTX), Lineage Cell Therapeutics (LCTX), BioTime (BTX), Arix Bioscience (ARIX), BiomX (PHGE), Rezolute (RZLT), Bellus Health (BLU), Verseon (VSN), Actinium Pharmaceuticals (ATNM), Actinium Pharmaceuticals (ATNM) and Immunoprecise Antibodies (IPA). View all competitors. What other stocks do shareholders of Ixico own? Based on aggregate information from My MarketBeat watchlists, some companies that other Ixico investors own include Motif Bio (MTFB), ReNeuron Group (RENE), Pendragon (PDG), Enquest (ENQ) and Chariot Oil & Gas (CHAR). Who are Ixico's key executives? Ixico's management team includes the following people: Mr. Giulio Cerroni, CEO & Director (Age 57)Prof. Derek Lionel Glendon Hill, Co-Founder and Pres of Regulatory Science & External Relations (Age 53)Prof. Daniel Rueckert, Co-Founder & Member of Scientific Advisory BoardProf. David Hawkes, Co-Founder & Member of Scientific Advisory BoardProf. Joseph Hajnal, Co-Founder & Member of Scientific Advisory Board What is Ixico's stock symbol? Ixico trades on the London Stock Exchange (LON) under the ticker symbol "IXI." How do I buy shares of Ixico? Shares of IXI and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Ixico's stock price today? One share of IXI stock can currently be purchased for approximately GBX 83. How big of a company is Ixico? Ixico has a market capitalization of £39.09 million and generates £8.69 million in revenue each year. Ixico employs 67 workers across the globe. What is Ixico's official website? The official website for Ixico is ixico.com. How can I contact Ixico? Ixico's mailing address is 4th Fl, Griffin Court, 15 Long Lane, LONDON, EC1A 9PN, United Kingdom. The company can be reached via phone at +44-20-37637499. This page was last updated on 9/25/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
